Protective effects of coffee-derived compounds on lipopolysaccharide/D- galactosamine induced acute liver injury in rats

Journal of Pharmacy and Pharmacology

Volumn 61, Issue 4, 2009, Pages 473-478

  Akashi, Iwao ^a   Kagami, Keisuke ^a   Hirano, Toshihiko ^a   Oka, Kitaro ^a  

^a TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

Author keywords

Caffeine; Coffee; Inflammation; Liver injury; Maillard reaction products; Pyrazine

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CAFFEINE; CHLOROGENIC ACID; GALACTOSAMINE; INTERLEUKIN 10; LIPOPOLYSACCHARIDE; NICOTINIC ACID; PYRAZINOIC ACID; SODIUM CHLORIDE; TRIGONELLINE; TUMOR NECROSIS FACTOR ALPHA; ALKALOID; DRUG DERIVATIVE; PYRAZINAMIDE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD SAMPLING; COFFEE; CONTROLLED STUDY; DRUG EFFICACY; LIVER INJURY; LIVER PROTECTION; MALE; NONHUMAN; RAT; SURVIVAL RATE; WISTAR RAT; ANIMAL; BLOOD; CHEMICALLY INDUCED DISORDER; CHEMISTRY; LIVER DISEASE; MORTALITY;

ALANINE TRANSAMINASE; ALKALOIDS; ANIMALS; ASPARTATE AMINOTRANSFERASES; CAFFEINE; CHLOROGENIC ACID; COFFEE; GALACTOSAMINE; INTERLEUKIN-10; LIPOPOLYSACCHARIDES; LIVER DISEASES; MALE; NIACIN; PYRAZINAMIDE; RATS; RATS, WISTAR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 85047682157     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp.61.04.0009     Document Type: Article

References (27)

1. Tanaka K et al. Coffee consumption and decreased serum gamma-glutamyltransferase and aminotransferase activities among male alcohol drinkers. Int J Epidemiol 1998; 27: 438-443.
2. Honjo S et al. Coffee consumption and serum aminotransferases in middle-aged Japanese men. J Clin Epidemiol 2001; 54: 823-829.
3. Ruhl CE, Everhart JE. Coffee and caffeine consumption reduce the risk of elevated serum alanine aminotransferase activity in the United States. Gastroenterology 2005; 128: 24-32.
4. La Vecchia, C. Coffee, liver enzymes, cirrhosis and liver cancer. J Hepatol 2005; 42: 444-446.
5. Ruhl CE, Everhart JE. Coffee and tea consumption are associated with a lower incidence of chronic liver disease in the United States. Gastroenterology 2005; 129: 1928-1936.
6. Minamisawa M et al. Determination of biologically active substances in roasted coffees using a diode-array HPLC system. Anal Sci 2004; 20: 325-328.
7. Horrigan LA et al. Immunomodulatory effects of caffeine: friend or foe? Pharmacol Ther 2006; 111: 877-892.
8. Oka K. Pharmacological bases of coffee nutrients for diabetes prevention. Yakugaku Zasshi 2007; 127: 1825-1836.
9. Kagami K et al. Protective effect of caffeine on streptozotocin-induced beta-cell damage in rats. J Pharm Pharmacol 2008; 60: 1161-1165.
10. Eigler A et al. Anti-inflammatory activities of cAMP-elevating agents: enhancement of IL-10 synthesis and concurrent suppression of TNF production. J Leukoc Biol 1998; 63: 101-107.
11. Procópio DO et al. Differential inhibitory mechanism of cyclic AMP on TNF-alpha and IL-12 synthesis by macrophages exposed to microbial stimuli. Br J Pharmacol 1999; 127: 1195-1205.
12. Dent G, Rabe KF. Effects of theophylline and non-selective xanthine derivatives on PDE isoenzymes and cellular function. In: Schudt C et al. eds. Phosphodiesterase Inhibitors. New York: Academic Press, 1996: 41-64.
13. Souness JE et al. Immunosuppressive and anti-inflammatory effects of cyclic AMP phosphodiesterase (PDE) type 4 inhibitors. Immunopharmacology 2000; 47: 127-162.
14. He P et al. Green tea suppresses lipopolysaccharide-induced liver injury in D-galactosamine-sensitized rats. J Nutr 2001; 131: 1560-1567.
15. He P et al. Suppressive effect of coffee on lipopolysaccharide- induced hepatitis in D-galactosamine-sensitized rats. Biosci Biotechnol Biochem 2001; 65: 1924-1927.
16. Kagami K et al. Suppression of blood lipid concentrations by volatile Maillard reaction products. Nutrition 2008; 24: 1159-1166.
17. Jacob AI et al. Endotoxin and bacteria in portal blood. Gastroenterology 1977; 72: 1268-1270.
18. Galanos C et al. Galactosamine-induced sensitization to the lethal effects of endotoxin. Proc Natl Acad Sci USA 1979; 76: 5939-5943.
19. Wan JY et al. Protective effect of baicalin against lipopolysaccharide/ D-galactosamine-induced liver injury in mice by up-regulation of heme oxygenase-1. Eur J Pharmacol 2008; 587: 302-308.
20. Basnet P et al. Four di-O-caffeoyl quinic acid derivatives from propolis. Potent hepatoprotective activity in experimental liver injury models. Biol Pharm Bull 1996; 19: 1479-1484.
21. Leist M et al. Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models. Am J Pathol 1995; 146: 1220-1234.
22. Jiang W et al. Toll-like receptor 3 ligand attenuates LPS-induced liver injury by down-regulation of toll-like receptor 4 expression on macrophages. Proc Natl Acad Sci USA 2005; 102: 17 077-17 082.
23. Arai T et al. IL-10 is involved in the protective effect of dibutyryl cyclic adenosine monophosphate on endotoxin-induced inflammatory liver injury. J Immunol 1995; 155: 5743-5749.
24. Taguchi I et al. Protection by a cyclic AMP-specific phosphodiesterase inhibitor, rolipram, and dibutyryl cyclic AMP against Propionibacterium acnes and lipopolysaccharide-induced mouse hepatitis. Inflamm Res 1999; 48: 380-385.
25. Ohta A et al. 1,3,7-Trimethylxanthine (caffeine) may exacerbate acute inflammatory liver injury by weakening the physiological immunosuppressive mechanism. J Immunol 2007; 179: 7431-7438.
26. Lorenzen A et al. Characterization of a G protein-coupled receptor for nicotinic acid. Mol Pharmacol 2001; 59: 349-357.
27. Offermanns S. The nicotinic acid receptor GPR109A (HM74A or PUMA-G) as a new therapeutic target. Trends Pharmacol Sci 2006; 27: 384-390.